MBX Biosciences, Inc. (MBX) Stock Statistics & Valuation Metrics

MBX Biosciences, Inc. has a market cap or net worth of $516.34M. The enterprise value is $157.38M.

MBX Biosciences, Inc. has 33,593,864 shares outstanding. The number of shares has decreased by -2.65% in one year.

MBX Biosciences, Inc.’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -26.45%.

The current PE Ratio of MBX Biosciences, Inc. is ―. MBX Biosciences, Inc.’s PEG ratio is ―.

In the last 12 months, MBX Biosciences, Inc. had revenue of 0.00 and earned -61.92M in profits. Earnings per share was -1.85.

In the last 12 months, operating cash flow was -70.81M and capital expenditures -886.00K, giving a free cash flow of -71.70M billion.

MBX Biosciences, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

MBX Biosciences, Inc. upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).

MBX Biosciences, Inc. as a current ratio of 24.19, with Debt / Equity ratio of 0.30%

In the past 12 months, MBX Biosciences, Inc. has paid 0.00 in taxes.

MBX Biosciences, Inc. EV to EBITDA ratio is -8.33, with an EV/FCF ratio of -10.19.

MBX Biosciences, Inc. has $224.91M in cash and marketable securities with $650.00K in debt, giving a net cash position of -$224.26M billion.

Gross margin is -74.77%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for MBX Biosciences, Inc. is $39.20, which is 11.43% higher than the current price. The consensus rating is Strong Buy